Natco Pharma updates: news & description

Presence

Natco Pharma develops, makes, and sells pharmaceutical products. Its main offerings include generic medicines, oncology treatments, active ingredients, and crop health products for hospitals, pharmacies, healthcare providers, and agricultural customers.

Natco Pharma products and services overview:

Generic medicines
Oncology drugs
Active ingredients
Crop health products
Specialty medicines

Revenue: ~$530 million

Employees: 4,000

Headquarters: Hyderabad, India

Natco Pharma is owned by Sun Pharma.

Sun Pharma is one of the...

Sun Pharma is a company listed under the stock ticker SUNPHARMA (IN).

Sun Pharma has a direct presence in 2 countries.

Sun Pharma has 4 subsidiaries including Chattem Chemicals, Natco Pharma and Sun Pharma USA.

They are in:

Pharmaceuticals80%
Chemicals20%

Acquisition, funding and merger involving Sun Pharma.

Natco Pharma has announced the acquisition of Adcock Ingram (posted on July 28 2025).

Executives

View the org chart displaying its 34 main executives

Most searched biographies at Natco Pharma

Popular executive movements at Natco Pharma

Amit Parekh, who was Finance Director, is promoted to Cheif Financial Officer (posted on February 24 2026).
S.V.V.N Appa Rao, Chief Financial Officer, is retiring (posted on February 24 2026).
Vijay Kiran Kumar has joined the company as Vice President, Corporate Quality Assurance Formulations (posted on October 14 2025).

Popular executive movements at Sun Pharma

Andreas Eugen Busch has joined the company as Director (posted on May 15 2026).
Sagar Mahajan has joined the company as General Manager, Business Development (posted on May 8 2026).
Rama Bijapurkar, Independent Director, will leave the company on May 20, 2026 (posted on February 3 2026).

Click here to view some more movements at Sun Pharma

Create your alert
to follow the executive moves at Natco Pharma.